A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.

NCT05668091 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Long COVID

Interventions

DRUG: Nirmatrelvir
DRUG: Ritonavir
DRUG: Placebo

Sponsor

Harlan M Krumholz

Collaborators

[object Object]